JPS57501510A - - Google Patents

Info

Publication number
JPS57501510A
JPS57501510A JP56503268A JP50326881A JPS57501510A JP S57501510 A JPS57501510 A JP S57501510A JP 56503268 A JP56503268 A JP 56503268A JP 50326881 A JP50326881 A JP 50326881A JP S57501510 A JPS57501510 A JP S57501510A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56503268A
Other languages
Japanese (ja)
Other versions
JPH0258920B2 (cg-RX-API-DMAC10.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803038163 external-priority patent/DE3038163A1/de
Application filed filed Critical
Publication of JPS57501510A publication Critical patent/JPS57501510A/ja
Publication of JPH0258920B2 publication Critical patent/JPH0258920B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8128—Antithrombin III
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP56503268A 1980-10-09 1981-10-08 Expired - Lifetime JPH0258920B2 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803038163 DE3038163A1 (de) 1980-10-09 1980-10-09 Thrombininhibitor, seine herstellung und verwendung
DE3050268 1981-08-04

Publications (2)

Publication Number Publication Date
JPS57501510A true JPS57501510A (cg-RX-API-DMAC10.html) 1982-08-26
JPH0258920B2 JPH0258920B2 (cg-RX-API-DMAC10.html) 1990-12-11

Family

ID=25788386

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56503268A Expired - Lifetime JPH0258920B2 (cg-RX-API-DMAC10.html) 1980-10-09 1981-10-08

Country Status (6)

Country Link
US (1) US4496653A (cg-RX-API-DMAC10.html)
EP (1) EP0049877B1 (cg-RX-API-DMAC10.html)
JP (1) JPH0258920B2 (cg-RX-API-DMAC10.html)
DE (1) DE3163764D1 (cg-RX-API-DMAC10.html)
DK (1) DK160511C (cg-RX-API-DMAC10.html)
WO (1) WO1982001377A1 (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3407280A1 (de) * 1984-02-28 1985-09-19 Gödecke AG, 1000 Berlin Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit
DE3512909A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Verfahren zur bestimmung von plasminogenaktivatoren (pa)
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
US5595735A (en) * 1990-05-23 1997-01-21 Johnson & Johnson Medical, Inc. Hemostatic thrombin paste composition
JP3094165B2 (ja) * 1990-11-05 2000-10-03 バクスター、ダイアグノスチックス、インコーポレイテッド 抗凝固剤濃度測定方法
DE4203980A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Verfahren zur bestimmung von hirudin und synthetischen thrombininhibitoren
AT397391B (de) * 1992-05-15 1994-03-25 Immuno Ag Verwendung von prothrombinfragmenten
AU4405293A (en) * 1992-06-05 1994-01-04 Barbara M. Alving Test for quantitative thrombin time
US5476771A (en) * 1993-02-22 1995-12-19 The United States Of America As Represented By The Secretary Of The Army Test for quantitative thrombin time
US5308755A (en) * 1992-06-08 1994-05-03 Research Corporation Technologies, Inc. Method for measuring heparin
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
EP3198272B1 (en) 2014-09-26 2022-04-06 Abbott Point Of Care, Inc. Cartridge device identification for coagulation assays in fluid samples
CN107110874B (zh) 2014-09-26 2019-06-04 雅培医护站股份有限公司 用于测定流体样品中的凝固的传感器
US10048282B2 (en) 2014-09-26 2018-08-14 Abbott Point Of Care Inc. Cartridge device with fluidic junctions for coagulation assays in fluid samples
EP3954457A3 (en) 2014-09-26 2022-05-18 Abbott Point Of Care Inc Microfabricated device with micro-environment sensors for assaying coagulation in fluid samples
CN106999930B (zh) 2014-09-26 2020-09-08 雅培医护站股份有限公司 用于测定流体样本中的凝结的具有分段射流的盒设备
WO2016049557A1 (en) 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Ellagic acid formulations for use in coagulation assays
US10114031B2 (en) 2014-09-26 2018-10-30 Abbott Point Of Care Inc. Single channel cartridge device for coagulation assays in fluid samples

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2338496A1 (fr) * 1976-01-15 1977-08-12 Behringwerke Ag Procede de dosage quantitatif de l'antithrombine iii
EP0004271A2 (de) * 1978-03-23 1979-10-03 Roche Diagnostics GmbH Verfahren und Reagens zur Bestimmung des biologisch aktiven Heparins im Plasma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622286A5 (cg-RX-API-DMAC10.html) * 1975-06-23 1981-03-31 Pentapharm Ag
SE419871B (sv) * 1975-12-01 1981-08-31 Pharmacia Ab Sett att bestemma aktiviteten hos faktor xa-inhibitor i blod
US4216142A (en) * 1978-12-18 1980-08-05 Abbott Laboratories Chromogenic substrates for the proteolytic enzymes
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
EP0018002B1 (de) * 1979-04-24 1983-02-09 Marcel Jozefonvicz Neues Bestimmungsverfahren für Proteasen und Antiproteasen
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2338496A1 (fr) * 1976-01-15 1977-08-12 Behringwerke Ag Procede de dosage quantitatif de l'antithrombine iii
EP0004271A2 (de) * 1978-03-23 1979-10-03 Roche Diagnostics GmbH Verfahren und Reagens zur Bestimmung des biologisch aktiven Heparins im Plasma

Also Published As

Publication number Publication date
DK160511C (da) 1991-09-30
DK237282A (da) 1982-05-26
JPH0258920B2 (cg-RX-API-DMAC10.html) 1990-12-11
DK160511B (da) 1991-03-18
EP0049877B1 (de) 1984-05-23
US4496653A (en) 1985-01-29
EP0049877A1 (de) 1982-04-21
WO1982001377A1 (en) 1982-04-29
DE3163764D1 (en) 1984-06-28

Similar Documents

Publication Publication Date Title
FR2481605B1 (cg-RX-API-DMAC10.html)
FR2473621B1 (cg-RX-API-DMAC10.html)
FR2474883B1 (cg-RX-API-DMAC10.html)
FR2483338B1 (cg-RX-API-DMAC10.html)
FR2488576B1 (cg-RX-API-DMAC10.html)
FR2474871B1 (cg-RX-API-DMAC10.html)
FR2477306B1 (cg-RX-API-DMAC10.html)
FR2487644B1 (cg-RX-API-DMAC10.html)
FR2483365B1 (cg-RX-API-DMAC10.html)
IN154853B (cg-RX-API-DMAC10.html)
FR2475015B3 (cg-RX-API-DMAC10.html)
FR2488476B1 (cg-RX-API-DMAC10.html)
FR2482621B1 (cg-RX-API-DMAC10.html)
FR2488624B1 (cg-RX-API-DMAC10.html)
FR2488653B1 (cg-RX-API-DMAC10.html)
FR2476428B1 (cg-RX-API-DMAC10.html)
FR2485682B1 (cg-RX-API-DMAC10.html)
FR2481280B1 (cg-RX-API-DMAC10.html)
FR2480486B1 (cg-RX-API-DMAC10.html)
FR2481425B1 (cg-RX-API-DMAC10.html)
FR2494744B1 (cg-RX-API-DMAC10.html)
FR2473986B3 (cg-RX-API-DMAC10.html)
FR2478421B1 (cg-RX-API-DMAC10.html)
FR2489669B1 (cg-RX-API-DMAC10.html)
FR2473480B1 (cg-RX-API-DMAC10.html)